Literature DB >> 16940841

Measurement of tetanus antitoxin in oral fluid: a tool to conduct serosurveys.

Milagritos D Tapia1, Marcela F Pasetti, Lilian Cuberos, Samba O Sow, Mama N Doumbia, Modibo Bagayogo, Karen L Kotloff, Myron M Levine.   

Abstract

BACKGROUND: Serosurveys that measure tetanus antitoxin can complement immunization coverage surveys to allow evaluation of immunization services in developing countries. Measurement of IgG tetanus antitoxin in oral fluid was investigated as a practical and noninvasive alternative to and correlate of serum antibodies.
METHODS: Serum and oral fluid were collected from Malian infants, toddlers and adults (males without a history of tetanus vaccination). Specific IgG tetanus antitoxin was measured by enzyme-linked immunosorbent assay in serum (S-ELISA) and oral fluid (OF-ELISA).
RESULTS: One hundred forty-two pairs of serum and oral fluid samples were collected from infants, 35 pairs from toddlers and 35 pairs from adults. IgG tetanus antitoxin titers measured by OF-ELISA were 100-fold lower than those measured by S-ELISA but they correlated strongly (r = 0.90, P < 0.001). All 35 toddlers who had received 2 or 3 doses of diphtheria-tetanus-pertussis (DTP) vaccine (100%) had serum tetanus antitoxin levels >or=0.15 IU/mL and 28 of 35 (80%) had oral fluid values >or=0.0015 IU/mL. Among adults lacking a history of tetanus immunization, only 6 of 35 (17.1%) had serum titers >or=0.15 IU/mL and 4 of 35 (11%) had oral fluid titers >or=0.0015 IU/mL in oral fluid.
CONCLUSIONS: IgG tetanus antitoxin in oral fluid correlates well with levels in serum. OF-ELISA values >or=0.0015 IU/mL constitute protection against tetanus and in subjects >12 months of age imply multiple prior contacts with immunization services. IgG tetanus antitoxin measured by OF-ELISA provides a logistically practical alternative for performing seroprevalence surveys.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16940841     DOI: 10.1097/01.inf.0000232629.72160.bb

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  9 in total

1.  Mucosal IgA responses in healthy adult volunteers following intranasal spray delivery of a live attenuated measles vaccine.

Authors:  Jakub K Simon; Karina Ramirez; Lilian Cuberos; James D Campbell; Jean F Viret; Alma Muñoz; Rosanna Lagos; Myron M Levine; Marcela F Pasetti
Journal:  Clin Vaccine Immunol       Date:  2011-01-12

2.  Use of IgG in oral fluid to monitor infants with suspected congenital toxoplasmosis.

Authors:  Emmanuelle Chapey; Valeria Meroni; François Kieffer; Lina Bollani; René Ecochard; Patricia Garcia; Martine Wallon; François Peyron
Journal:  Clin Vaccine Immunol       Date:  2015-02-04

3.  Serological Monitoring Is Key To Sustain Progress of the Maternal and Neonatal Tetanus Elimination Initiative.

Authors:  Myron M Levine; Marcela F Pasetti
Journal:  Clin Vaccine Immunol       Date:  2016-07-05

4.  Human saliva as a source of anti-malarial antibodies to examine population exposure to Plasmodium falciparum.

Authors:  Patricia Tabernero Estévez; Judith Satoguina; Davis C Nwakanma; Sheila West; David J Conway; Chris J Drakeley
Journal:  Malar J       Date:  2011-04-29       Impact factor: 2.979

5.  Measles vaccination coverage estimates from surveys, clinic records, and immune markers in oral fluid and blood: a population-based cross-sectional study.

Authors:  Kyla T Hayford; Mohammed S Shomik; Hassan M Al-Emran; William J Moss; David Bishai; Orin S Levine
Journal:  BMC Public Health       Date:  2013-12-20       Impact factor: 3.295

6.  A systematic review of the agreement of recall, home-based records, facility records, BCG scar, and serology for ascertaining vaccination status in low and middle-income countries.

Authors:  Emily Dansereau; David Brown; Lena Stashko; M Carolina Danovaro-Holliday
Journal:  Gates Open Res       Date:  2020-02-03

7.  Adjustments for oral fluid quality and collection methods improve prediction of circulating tetanus antitoxin: Approaches for correcting antibody concentrations detected in a non-invasive specimen.

Authors:  Henri Garrison-Desany; Benard Omondi Ochieng; Maurice R Odiere; Helen Kuo; Dustin G Gibson; Joyce Were; E Wangeci Kagucia; Marcela F Pasetti; Hani Kim; Mardi Reymann; Katherine O'Brien; Kyla Hayford
Journal:  Vaccine       Date:  2020-11-27       Impact factor: 3.641

Review 8.  Measuring coverage in MNCH: design, implementation, and interpretation challenges associated with tracking vaccination coverage using household surveys.

Authors:  Felicity T Cutts; Hector S Izurieta; Dale A Rhoda
Journal:  PLoS Med       Date:  2013-05-07       Impact factor: 11.069

9.  Immunization Coverage Surveys and Linked Biomarker Serosurveys in Three Regions in Ethiopia.

Authors:  Mark A Travassos; Berhane Beyene; Zenaw Adam; James D Campbell; Nigisti Mulholland; Seydou S Diarra; Tassew Kassa; Lisa Oot; Jenny Sequeira; Mardi Reymann; William C Blackwelder; Yukun Wu; Inna Ruslanova; Jaya Goswami; Samba O Sow; Marcela F Pasetti; Robert Steinglass; Amha Kebede; Myron M Levine
Journal:  PLoS One       Date:  2016-03-02       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.